LiteFold/IEDB huggingface dataset:
Reference: Lis Noelia Velasquez; Philipp Stüve; Maria Virginia Gentilini; Maxine Swallow; Judith Bartel; Nils Yngve Lycke; Daniel Barkan; Mariana Martina; Hugo D Lujan; Hakan Kalay; Yvette van Kooyk; Tim D Sparwasser; Luciana Berod. "Targeting  Antigens to Dendritic Cells  the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses." Frontiers in immunology (2018).

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive-Low
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Negative
Host:  12-18 weeks

Epitope: P25
Chemical type: Peptide from protein
Sequence: FQDAYNAAGGHNAVF
Position: 280-294
Source molecule (GenBank): P0C5B9.1
Assay category: TCell
Result: Positive-Low
Host:  12-18 weeks
Cell type: T cell CD4+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Nastaran Barati; Atefeh Razazan; Jessica Nicastro; Roderick Slavcev; Atefeh Arab; Fatemeh Mosaffa; Amin Reza Nikpoor; Ali Badiee; Mahmoud Reza Jaafari; Javad Behravan. "Immunogenicity and antitumor activity of the superlytic λF7 phage nanoparticles displaying a HER2/neu-derived peptide AE37 in a tumor model of BALB/c mice." Cancer letters (2018).

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive
Cell type: splenocyte
Tissue: spleen
Culture conditions: Short Term Restimulated

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive

Epitope: AE37
Chemical type: Peptide, no natural source
Sequence: LRMKGVGSPYVSRLLGICL
Assay category: TCell
Result: Positive
Reference: Yusuke Oji; Masayoshi Inoue; Yoshito Takeda; Naoki Hosen; Yasushi Shintani; Manabu Kawakami; Takuya Harada; Yui Murakami; Miki Iwai; Mari Fukuda; Sumiyuki Nishida; Jun Nakata; Yoshiki Nakae; Satoshi Takashima; Toshiaki Shirakata; Hiroko Nakajima; Kana Hasegawa; Hiroshi Kida; Takashi Kijima; Soyoko Morimoto; Fumihiro Fujiki; Akihiro Tsuboi; Eiichi Morii; Satoshi Morita; Junichi Sakamoto; Atsushi Kumanogoh; Yoshihiro Oka; Meinoshin Okumura; Haruo Sugiyama. "WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies." International journal of cancer. Journal international du cancer (2018).

Epitope: mWT1-235
Chemical type: Peptide, no natural source
Sequence: CYTWNQMNL
Assay category: BCell
Result: Positive

Epitope: mWT1-235
Chemical type: Peptide, no natural source
Sequence: CYTWNQMNL
Assay category: BCell
Result: Positive

Epitope: mWT1-235
Chemical type: Peptide, no natural source
Sequence: CYTWNQMNL
Assay category: BCell
Result: Positive

Epitope: mWT1-235
Chemical type: Peptide, no natural source
Sequence: CYTWNQMNL
Assay category: TCell
Result: Positive
Reference: Cunbao Liu; Xiaojie Chu; Pengyan Sun; Xuejun Feng; Weiwei Huang; Hongxian Liu; Yanbing Ma. "Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model." Human vaccines & immunotherapeutics (2018).

Epitope: E7(44-62)
Chemical type: Peptide from protein
Sequence: QAEPDRAHYNIVTFCCKCD
Position: 44-62
Source molecule (GenBank): P03129
Assay category: TCell
Result: Positive
Host: F 6-8 weeks

Epitope: E7(44-62)
Chemical type: Peptide from protein
Sequence: QAEPDRAHYNIVTFCCKCD
Position: 44-62
Source molecule (GenBank): P03129
Assay category: TCell
Result: Positive
Host: F 6-8 weeks
Cell type: T cell CD8+
Tissue: spleen
Culture conditions: Direct Ex Vivo
Reference: Pedro O Flores-Villanueva; Malathesha Ganachari; Heinner Guio; Jaime A Mejia; Julio Granados. "An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8<sup>+</sup> T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines." Journal of immunology (Baltimore, Md. : 1950) (2018).

Epitope: CT37 (89-98)
Chemical type: Peptide from protein
Sequence: YLCSGSSYFV
Position: 89-98
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-98)
Chemical type: Peptide from protein
Sequence: YLCSGSSYFV
Position: 89-98
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-98)
Chemical type: Peptide from protein
Sequence: YLCSGSSYFV
Position: 89-98
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-98)
Chemical type: Peptide from protein
Sequence: YLCSGSSYFV
Position: 89-98
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-98)
Chemical type: Peptide from protein
Sequence: YLCSGSSYFV
Position: 89-98
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-98)
Chemical type: Peptide from protein
Sequence: YLCSGSSYFV
Position: 89-98
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-97)
Chemical type: Peptide from protein
Sequence: YLCSGSSYF
Position: 89-97
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone

Epitope: CT37 (89-97)
Chemical type: Peptide from protein
Sequence: YLCSGSSYF
Position: 89-97
Source molecule (GenBank): Q8N0W7.1
Assay category: TCell
Result: Positive
Cell type: T cell CD8+
Tissue: blood
Culture conditions: Cell Line / Clone
Reference: Kosei Hasegawa; Yuji Ikeda; Yuko Kunugi; Akira Kurosaki; Yuichi Imai; Shunsuke Kohyama; Shoji Nagao; Eito Kozawa; Koji Yoshida; Takuya Tsunoda; Yusuke Nakamura; Keiichi Fujiwara. "Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer." Journal of immunotherapy (Hagerstown, Md. : 1997) (2018).

Epitope: FOXM1-262
Chemical type: Peptide from protein
Sequence: IYTWIEDHF
Position: 262-270
Source molecule (GenBank): Q08050.3
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: FOXM1-262
Chemical type: Peptide from protein
Sequence: IYTWIEDHF
Position: 262-270
Source molecule (GenBank): Q08050.3
Assay category: TCell
Result: Positive-High
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MELK-87-7N
Chemical type: Peptide, no natural source
Sequence: EYCPGGNLF
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: MELK-87-7N
Chemical type: Peptide, no natural source
Sequence: EYCPGGNLF
Assay category: TCell
Result: Positive-High
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: HJURP-408
Chemical type: Peptide from protein
Sequence: KWLISPVKI
Position: 408-416
Source molecule (GenBank): Q8NCD3.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: HJURP-408
Chemical type: Peptide from protein
Sequence: KWLISPVKI
Position: 408-416
Source molecule (GenBank): Q8NCD3.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: VEGFR1-1084
Chemical type: Peptide from protein
Sequence: SYGVLLWEI
Position: 1084-1092
Source molecule (GenBank): P17948.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: VEGFR1-1084
Chemical type: Peptide from protein
Sequence: SYGVLLWEI
Position: 1084-1092
Source molecule (GenBank): P17948.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: VEGFR2-169
Chemical type: Peptide from protein
Sequence: RFVPDGNRI
Position: 169-177
Source molecule (GenBank): P35968.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo

Epitope: VEGFR2-169
Chemical type: Peptide from protein
Sequence: RFVPDGNRI
Position: 169-177
Source molecule (GenBank): P35968.2
Assay category: TCell
Result: Positive-Low
Cell type: PBMC
Tissue: blood
Culture conditions: Direct Ex Vivo
Reference: Miriam Palacios; Ricardo Tampe; Miguel Del Campo; Ta-Ying Zhong; Mercedes N López; Flavio Salazar-Onfray; María Inés Becker. "Antitumor activity and carrier properties of novel hemocyanins coupled to a mimotope of GD2 ganglioside." European journal of medicinal chemistry (2018).

Epitope: P10 (mimotope of GD2)
Chemical type: Peptide, no natural source
Sequence: GVVWRYTAPVHLGDG
Assay category: BCell
Result: Positive
Host:  8-12 weeks

Epitope: P10 (mimotope of GD2)
Chemical type: Peptide, no natural source
Sequence: GVVWRYTAPVHLGDG
Assay category: BCell
Result: Positive
Host:  8-12 weeks

Epitope: P10 (mimotope of GD2)
Chemical type: Peptide, no natural source
Sequence: GVVWRYTAPVHLGDG
Assay category: TCell
Result: Positive
Host:  8-12 weeks
Reference: Sanae Tabata; Yu Kitago; Yuki Fujii; Emiko Mihara; Keiko Tamura-Kawakami; Naoko Norioka; Katsu Takahashi; Mika K Kaneko; Yukinari Kato; Junichi Takagi. "An anti-peptide monoclonal antibody recognizing the tobacco etch virus protease-cleavage sequence and its application to a tandem tagging system." Protein expression and purification (2018).

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Host: F 8 weeks

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Host: F 8 weeks

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Quantitative measurement: 2.05
Host: F 8 weeks

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Host: F 8 weeks

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Quantitative measurement: 71.4
Host: F 8 weeks

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Quantitative measurement: 502000.0
Host: F 8 weeks

Epitope: eTev
Chemical type: Peptide, no natural source
Sequence: RENLYFQGKDG
Assay category: BCell
Result: Positive
Quantitative measurement: 0.0359
Host: F 8 weeks

Epitope: PA tag
Chemical type: Peptide from protein
Sequence: GVAMPGAEDDVV
Position: 40-51
Source molecule (GenBank): Q86YL7.3
Assay category: BCell
Result: Positive
Host: F
Reference: Annekathrin Haberland; Martin Holtzhauer; Alice Schlichtiger; Sabine Bartel; Ingolf Schimke; Johannes Müller; Michael Dandel; Peter B Luppa; Gerd Wallukat. "Aptamer BC 007 - A broad spectrum neutralizer of pathogenic autoantibodies against G-protein-coupled receptors." European journal of pharmacology (2016).

Epitope: ETA peptide 4301.1
Chemical type: Peptide from protein
Sequence: FYQDVKD
Position: 250-256
Source molecule (GenBank): P25101.1
Assay category: BCell
Result: Positive

Epitope: aptamer BC 007
Chemical type: Other Non-Sequence
Assay category: BCell
Result: Positive
Epitope: N10
Chemical type: Peptide from protein
Sequence: LMAMMHLSGQEVTMW
Position: 22-36
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low

Epitope: N11
Chemical type: Peptide from protein
Sequence: KQIRIGFSLPKETEE
Position: 65-79
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low

Epitope: N16
Chemical type: Peptide from protein
Sequence: PASRRLYREYEALFV
Position: 170-184
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low

Epitope: N18
Chemical type: Peptide from protein
Sequence: YRIPSILKTANGTLI
Position: 193-207
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low

Epitope: N17
Chemical type: Peptide from protein
Sequence: FGDVALVQTQAGKLL
Position: 254-268
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low

Epitope: N6
Chemical type: Peptide from protein
Sequence: LKTANGTLIAMADRR
Position: 199-213
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low

Epitope: N15
Chemical type: Peptide from protein
Sequence: QAGKLLMIFVGGVGL
Position: 263-277
Source molecule (GenBank): BAG34127.1
Assay category: BCell
Result: Positive-Low
Reference: Mengnan He; Yan Chai; Jianxun Qi; Catherine W H Zhang; Zhou Tong; Yi Shi; Jinghua Yan; Shuguang Tan; George F Gao. "Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies." Oncotarget (2017).

Epitope: Epitope of ipilimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, M38, E68, R70, L74, S79, V81, T82, E83, K130, E132, M134, Y135, P136, P137, P138, Y139, Y140, L141, G142, I143
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 3.2

Epitope: Epitope of ipilimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, M38, E68, R70, L74, S79, V81, T82, E83, K130, E132, M134, Y135, P136, P137, P138, Y139, Y140, L141, G142, I143
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 18.2

Epitope: Epitope of ipilimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, M38, E68, R70, L74, S79, V81, T82, E83, K130, E132, M134, Y135, P136, P137, P138, Y139, Y140, L141, G142, I143
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 383000.0

Epitope: Epitope of ipilimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, M38, E68, R70, L74, S79, V81, T82, E83, K130, E132, M134, Y135, P136, P137, P138, Y139, Y140, L141, G142, I143
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 0.00696

Epitope: Epitope of tremelimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, A37, M38, E68, R70, Q76, S79, Q80, V81, E83, L126, I128, K130, E132, M134, P137, P138, Y139, Y140, L141, I143, N145
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 5.89

Epitope: Epitope of tremelimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, A37, M38, E68, R70, Q76, S79, Q80, V81, E83, L126, I128, K130, E132, M134, P137, P138, Y139, Y140, L141, I143, N145
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 308000.0

Epitope: Epitope of tremelimumab on CTLA-4
Chemical type: Discontinuous protein residues
Discontinuous residues: K36, A37, M38, E68, R70, Q76, S79, Q80, V81, E83, L126, I128, K130, E132, M134, P137, P138, Y139, Y140, L141, I143, N145
Source molecule (GenBank): P16410.3
Assay category: BCell
Result: Positive
Quantitative measurement: 0.0018
Reference: Vaheh Oganesyan; Li Peng; Jared S Bee; John Li; Samuel R Perry; Frank Comer; Linda Xu; Kimberly Cook; Kannaki Senthil; Lori Clarke; Kim Rosenthal; Changshou Gao; Melissa Damschroder; Herren Wu; William Dall'Acqua. "Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody." The Journal of biological chemistry (2018).

Epitope: Epitope of 39S Fab on HER2 receptor
Chemical type: Discontinuous protein residues
Discontinuous residues: K200, V219, C220, A221, G222, G223, C224, P230, L231, P232, T233, C235, E238
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive
Quantitative measurement: 3.77

Epitope: Epitope of 39S Fab on HER2 receptor
Chemical type: Discontinuous protein residues
Discontinuous residues: K200, V219, C220, A221, G222, G223, C224, P230, L231, P232, T233, C235, E238
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 39S Fab on HER2 receptor
Chemical type: Discontinuous protein residues
Discontinuous residues: K200, V219, C220, A221, G222, G223, C224, P230, L231, P232, T233, C235, E238
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 39S Fab on HER2 receptor
Chemical type: Discontinuous protein residues
Discontinuous residues: K200, V219, C220, A221, G222, G223, C224, P230, L231, P232, T233, C235, E238
Source molecule (GenBank): P04626.1
Assay category: BCell
Result: Positive
Reference: Joost Snijder; Michael S Ortego; Connor Weidle; Andrew B Stuart; Matthew D Gray; M Juliana McElrath; Marie Pancera; David Veesler; Andrew T McGuire. "An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus." Immunity (2018).

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive
Quantitative measurement: 0.12

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive
Quantitative measurement: 0.0000387

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive
Quantitative measurement: 334000.0

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive

Epitope: AMMO1 epitope
Chemical type: Region on multi-chain protein
Discontinuous residues: A: L69, N70, K73, Y76, K77, T78, S79, P214, S215, F232, V233, Y235, H239, V243; B: L123, F124, G125, A126, L128
Source molecule (GenBank): YP_401700.1
Assay category: BCell
Result: Positive
Reference: Lucy Rutten; Yen-Ting Lai; Sven Blokland; Daphne Truan; Ilona J M Bisschop; Nika M Strokappe; Annemart Koornneef; Danielle van Manen; Gwo-Yu Chuang; S Katie Farney; Hanneke Schuitemaker; Peter D Kwong; Johannes P M Langedijk. "A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers." Cell reports (2018).

Epitope: Epitope of 35O22 Fab on HIV-1 gp120/gp41
Chemical type: Region on multi-chain protein
Discontinuous residues: B: G28, T30, E121, D122, D125, N126, T128, Q131, R134; G: E86, N87, T89, P234, N236
Source molecule (GenBank): AAM90825.1
Assay category: BCell
Result: Positive
Quantitative measurement: 2.714

Epitope: Epitope of 35O22 Fab on HIV-1 gp120/gp41
Chemical type: Region on multi-chain protein
Discontinuous residues: B: G28, T30, E121, D122, D125, N126, T128, Q131, R134; G: E86, N87, T89, P234, N236
Source molecule (GenBank): AAM90825.1
Assay category: BCell
Result: Positive

Epitope: Epitope of 3H+109L Fab on HIV-1 gp120
Chemical type: Discontinuous protein residues
Discontinuous residues: N132, V133, N135, I317, I318, G319, D320, I321, R322, Q323, H325, P405
Source molecule (GenBank): ADM30337.1
Assay category: BCell
Result: Positive
Quantitative measurement: 2.714
Reference: Fei Zhang; Xiaoqiang Qi; Xiaoxiao Wang; Diyang Wei; Jiawei Wu; Lingling Feng; Haiyan Cai; Yugang Wang; Naiyan Zeng; Ting Xu; Aiwu Zhou; Ying Zheng. "Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab." Oncotarget (2017).

Epitope: Epitope of atezolizumab on PD-L1
Chemical type: Discontinuous protein residues
Discontinuous residues: D49, A52, I54, Y56, E58, M59, E60, D61, K62, N63, Q66, V68, H69, V111, R113, M115, G119, G120, A121, D122, Y123, R125
Source molecule (GenBank): Q9NZQ7.1
Assay category: BCell
Result: Positive
Quantitative measurement: 2.9

Epitope: Epitope of atezolizumab on PD-L1
Chemical type: Discontinuous protein residues
Discontinuous residues: D49, A52, I54, Y56, E58, M59, E60, D61, K62, N63, Q66, V68, H69, V111, R113, M115, G119, G120, A121, D122, Y123, R125
Source molecule (GenBank): Q9NZQ7.1
Assay category: BCell
Result: Positive
Quantitative measurement: 9.96

Epitope: Epitope of KN035 on PD-L1
Chemical type: Discontinuous protein residues
Discontinuous residues: I54, Y56, E58, E60, D61, K62, N63, Q66, V68, H69, D73, R113, M115, S117, G120, A121, D122, Y123, R125
Source molecule (GenBank): Q9NZQ7.1
Assay category: BCell
Result: Positive
Quantitative measurement: 3.0